Insider Transactions in Q1 2021 at Eli Lilly & CO (LLY)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
51
+50.0%
|
$9,639
$189.16 P/Share
|
|
Mar 15
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.02%
|
$1,890
$189.16 P/Share
|
|
Mar 15
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
58
+0.12%
|
$10,962
$189.16 P/Share
|
|
Mar 09
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
59,959
-0.01%
|
$12,591,390
$210.61 P/Share
|
|
Mar 08
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
125,284
-0.06%
|
$26,184,356
$209.7 P/Share
|
|
Mar 01
2021
|
Anat Hakim EVP, GC & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,493
-44.06%
|
$712,572
$204.89 P/Share
|
|
Mar 01
2021
|
Anat Hakim EVP, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
7,928
+50.0%
|
-
|
|
Feb 16
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
53
+0.11%
|
$10,971
$207.76 P/Share
|
|
Feb 16
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.02%
|
$2,050
$205.76 P/Share
|
|
Feb 08
2021
|
Anat Ashkenazi EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,975
+23.7%
|
$1,634,875
$205.77 P/Share
|
|
Feb 08
2021
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Grant, award, or other acquisition
|
Direct |
9,594
+21.7%
|
$1,966,770
$205.77 P/Share
|
|
Feb 08
2021
|
Stephen F Fry SVP, HR & Diversity |
BUY
Grant, award, or other acquisition
|
Direct |
26,133
+16.25%
|
$5,357,265
$205.77 P/Share
|
|
Feb 08
2021
|
Patrik Jonsson EVP&Pres, LLY Dia&Obe, LLY USA |
BUY
Grant, award, or other acquisition
|
Direct |
5,595
+15.43%
|
$1,146,975
$205.77 P/Share
|
|
Feb 08
2021
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
6,350
+20.32%
|
$1,301,750
$205.77 P/Share
|
|
Feb 08
2021
|
Johna Norton EVP, Global Quality |
BUY
Grant, award, or other acquisition
|
Direct |
6,040
+19.17%
|
$1,238,200
$205.77 P/Share
|
|
Feb 08
2021
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
21,052
+22.5%
|
$4,315,660
$205.77 P/Share
|
|
Feb 08
2021
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Grant, award, or other acquisition
|
Direct |
10,791
+36.8%
|
$2,212,155
$205.77 P/Share
|
|
Feb 08
2021
|
David A Ricks President, Chair, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
130,343
+22.84%
|
$26,720,315
$205.77 P/Share
|
|
Feb 08
2021
|
Aarti S. Shah SVP & CIDO |
BUY
Grant, award, or other acquisition
|
Direct |
11,033
+25.87%
|
$2,261,765
$205.77 P/Share
|
|
Feb 08
2021
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Grant, award, or other acquisition
|
Direct |
18,521
+13.8%
|
$3,796,805
$205.77 P/Share
|
|
Feb 08
2021
|
Joshua L Smiley |
BUY
Grant, award, or other acquisition
|
Direct |
25,409
+24.65%
|
$5,208,845
$205.77 P/Share
|
|
Feb 08
2021
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
4,718
+12.24%
|
$967,190
$205.77 P/Share
|
|
Feb 08
2021
|
Ilya Yuffa EVP & President, LLY Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
3,536
+25.47%
|
$724,880
$205.77 P/Share
|
|
Feb 08
2021
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,247
+32.09%
|
$870,635
$205.77 P/Share
|
|
Feb 08
2021
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
29,037
+33.77%
|
$5,952,585
$205.77 P/Share
|
|
Feb 01
2021
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Payment of exercise price or tax liability
|
Direct |
2,403
-8.76%
|
$497,421
$207.97 P/Share
|
|
Feb 01
2021
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
BUY
Exercise of conversion of derivative security
|
Direct |
5,445
+16.57%
|
-
|
|
Feb 01
2021
|
Stephen F Fry SVP, HR & Diversity |
SELL
Payment of exercise price or tax liability
|
Direct |
6,746
-5.85%
|
$1,396,422
$207.97 P/Share
|
|
Feb 01
2021
|
Stephen F Fry SVP, HR & Diversity |
BUY
Exercise of conversion of derivative security
|
Direct |
15,078
+11.57%
|
-
|
|
Feb 01
2021
|
Johna Norton EVP, Global Quality |
SELL
Payment of exercise price or tax liability
|
Direct |
1,529
-7.3%
|
$316,503
$207.97 P/Share
|
|
Feb 01
2021
|
Johna Norton EVP, Global Quality |
BUY
Exercise of conversion of derivative security
|
Direct |
3,435
+14.08%
|
-
|
|
Feb 01
2021
|
Myles O'Neill SVP & Pres., Mfg. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,438
-9.55%
|
$1,125,666
$207.97 P/Share
|
|
Feb 01
2021
|
Myles O'Neill SVP & Pres., Mfg. Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
12,146
+17.59%
|
-
|
|
Feb 01
2021
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,854
-26.94%
|
$590,778
$207.97 P/Share
|
|
Feb 01
2021
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
6,282
+37.23%
|
-
|
|
Feb 01
2021
|
David A Ricks President, Chair, and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
33,738
-9.82%
|
$6,983,766
$207.97 P/Share
|
|
Feb 01
2021
|
David A Ricks President, Chair, and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
75,387
+17.99%
|
-
|
|
Feb 01
2021
|
Aarti S. Shah SVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-11.9%
|
$575,460
$207.97 P/Share
|
|
Feb 01
2021
|
Aarti S. Shah SVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,282
+21.19%
|
-
|
|
Feb 01
2021
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,490
-21.16%
|
$1,550,430
$207.97 P/Share
|
|
Feb 01
2021
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
16,754
+32.12%
|
-
|
|
Feb 01
2021
|
Joshua L Smiley |
SELL
Payment of exercise price or tax liability
|
Direct |
8,452
-13.92%
|
$1,749,564
$207.97 P/Share
|
|
Feb 01
2021
|
Joshua L Smiley |
BUY
Exercise of conversion of derivative security
|
Direct |
19,266
+24.09%
|
-
|
|
Jan 19
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.02%
|
$1,980
$198.48 P/Share
|
|
Jan 19
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.11%
|
$10,890
$198.48 P/Share
|
|
Jan 15
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.06%
|
$40,850,000
$190.31 P/Share
|
|
Jan 13
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.06%
|
$39,060,000
$186.33 P/Share
|
|
Jan 11
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.05%
|
$40,920,000
$186.24 P/Share
|